Stop TB Partnership

Accelerator for Impact (a4i)

Accelerator for Impact (a4i) is a synthetic venture capital fund/mechanism for the TB and global health space, which aims to catalyze the rapid roll-out of new TB and AMR products and technologies in high burden countries by:

  1. Focusing on the downstream end of the product development lifecycle;
  2. Providing technical guidance in navigating the global health market;
  3. Financing critical activities for roll-out (post-commercialization); and
  4. Creating a network of innovators, early adopter countries, key partners, and an operating team of functional specialists dedicated to executing an efficient pathway for introduction and scale-up.

The initiative was soft launched in November 2016 after its 1st Stakeholder Consultation, which was held in Liverpool, United Kingdom on 26 October 2016 in advance of the 47th Union World Conference on Lung Health

While a4i has identified diagnostics/adjunct technologies and digital health solutions as the first areas for investment and support, it will broaden its scope in the near future to include additional innovations.

  • Information deck (under construction)
  • Business plan (under construction)
  • Investment portfolio (under construction)
  • Key achievements (under construction)